Simultaneous occurrence of rejection and graft-versus-host reaction after allogeneic small bowel transplantation.
Small bowel transplantation may be complicated not only by rejection but also by graft-versus-host reaction (GVHR). So far, little is known about the association between these two immunological reactions, partly because of the lack of standardized, reproducible experimental models for such studies. In this work, a rat model in which GVHR and rejection occur simultaneously was established. When transplanting small bowel grafts from BN donors to Lewis recipients and thereafter treating the grafts locally with the immunomodulating substance LS-2616, a clinically visible GVHR occurred on day 6, at the same time the first signs of rejection became visible. The GVHR was confirmed by immunohistochemical staining for MHC class II-positive cells in liver and ear skin biopsy specimens. An obvious quantitative difference in the number of positive cells in both organs was observed when local treatment was compared with oral LS-2616 treatment or with findings in organs from untreated animals. We conclude that GVHR and rejection are not mutually exclusive and thus may occur simultaneously, and that this pharmacological model might facilitate further studies of the impact of GVHR on graft rejection and recipient survival.
Johnsson
C
C
Department of Transplantation Surgery, University Hospital, Uppsala, Sweden.
Gannedahl
G
G
Scheynius
A
A
Tufveson
G
G
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D006084:Graft Rejection / Q000276:immunology*; D006087:Graft vs Host Reaction / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D006912:Hydroxyquinolines / Q000494:pharmacology*; D007124:Immunoenzyme Techniques; D007421:Intestine, Small / Q000637:transplantation*; D008099:Liver / Q000276:immunology; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013997:Time Factors; D014184:Transplantation, Homologous
D000276:Adjuvants, Immunologic; D000949:Histocompatibility Antigens Class II; D006912:Hydroxyquinolines; C045282:roquinimex